CRL
Charles River Laboratories
310.80$
+7.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.1% | +4.2% | +6.0% | +39.5% | +9.0% | +13.6% | +39.2% | -18.6% | +10.4% | +7.4% | +0.4% | |
| – | -1.6% | +33.5% | +3.6% | +23.3% | +22.4% | +18.6% | +13.0% | +14.4% | +3.4% | +15.2% | +11.5% | |
| – | +29.3% | +8.8% | +0.8% | +7.6% | +21.0% | -1.6% | +26.9% | +3.0% | -2.1% | -3.0% | +1.7% | |
| – | +0.1% | +56.9% | +25.2% | -37.3% | -32.7% | +225.1% | -68.6% | -321.4% | – | – | – | |
| – | – | -412.1% | – | +149.3% | -58.3% | -525.2% | – | -455.3% | – | – | – | |
| – | +11.1% | -12.6% | +49.1% | +69.9% | +0.3% | +18.5% | +37.4% | +41.9% | -1.9% | -26.9% | -5.9% | |
| – | +7.5% | +114.3% | -89.4% | +1,215.7% | -28.6% | -11.7% | +139.0% | -57.7% | -7.4% | -56.5% | -14.6% | |
| – | – | – | – | – | – | +34.9% | -2.0% | – | – | – | – | |
| – | -3.7% | -89.6% | +771.5% | -87.0% | +30.6% | +32.6% | +69.8% | -5.1% | -37.5% | +393.4% | +202.6% | |
| – | -28.0% | +416.1% | -134.9% | – | -57.6% | -86.5% | +2,090.3% | -97.0% | -480.5% | +447.2% | -70.5% | |
| – | -92.6% | +8,491.2% | -153.4% | – | -58.4% | -79.6% | +1,323.5% | -106.3% | +101.7% | +544.2% | -2.6% | |
| – | -1,127.2% | – | – | -33.3% | +37.9% | -116.2% | – | -138.7% | – | -282.4% | – | |
| – | +14.9% | +8.9% | -3.8% | +28.8% | +13.1% | +11.6% | +40.0% | -44.6% | +23.9% | +37.3% | +3.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.